MetaStat, Inc. announced the presentation of supportive data for the role of Mena protein isoforms in tumor dissemination at the 2017 American Association of Cancer Research Annual meeting in Washington D.C. The poster was presented on April 4, 2017 by the company’s collaboration partner, Albert Einstein College of Medicine. In the current study of tumor-bearing mice, paclitaxel treatment was shown to increase the number of MetaSites (TMEM), circulating tumor cells and lung metastasis. Expression of MenaINV protein and mRNA also increased following paclitaxel treatment. In addition, previously published work from the company’s collaboration partner at MIT, demonstrated Mena confers resistance to paclitaxel treatment, and that Mena and MenaINV protein levels increased in response to paclitaxel therapy (Oudin et al., Mol Cancer Ther. 2017 Jan; 16(1):143-155).